312 related articles for article (PubMed ID: 26851203)
1. Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin.
Mutalik S; Suthar NA; Managuli RS; Shetty PK; Avadhani K; Kalthur G; Kulkarni RV; Thomas R
Int J Biol Macromol; 2016 May; 86():709-20. PubMed ID: 26851203
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
3. Novel spray dried pH-sensitive polyacrylamide-grafted-carboxymethylcellulose sodium copolymer microspheres for colon targeted delivery of an anti-cancer drug.
Alange VV; Birajdar RP; Kulkarni RV
J Biomater Sci Polym Ed; 2017 Feb; 28(2):139-161. PubMed ID: 27808009
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of water dispersed nanoparticles from different polysaccharides and their application in drug release.
Ayadi F; Bayer IS; Marras S; Athanassiou A
Carbohydr Polym; 2016 Jan; 136():282-91. PubMed ID: 26572357
[TBL] [Abstract][Full Text] [Related]
5. Functionally modified polyacrylamide-graft-gum karaya pH-sensitive spray dried microspheres for colon targeting of an anti-cancer drug.
Alange VV; Birajdar RP; Kulkarni RV
Int J Biol Macromol; 2017 Sep; 102():829-839. PubMed ID: 28392387
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
7. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S
Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273
[TBL] [Abstract][Full Text] [Related]
8. Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder.
Sharma M; Sharma S; Wadhwa J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):45-55. PubMed ID: 30663410
[TBL] [Abstract][Full Text] [Related]
9. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
Liu C; Cheng F; Yang X
J Agric Food Chem; 2017 Mar; 65(11):2426-2434. PubMed ID: 28249113
[TBL] [Abstract][Full Text] [Related]
13. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
14. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
15. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
16. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible Polyelectrolyte Complex Nanoparticles from Lactoferrin and Pectin as Potential Vehicles for Antioxidative Curcumin.
Yan JK; Qiu WY; Wang YY; Wu JY
J Agric Food Chem; 2017 Jul; 65(28):5720-5730. PubMed ID: 28657749
[TBL] [Abstract][Full Text] [Related]
18. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
19. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications.
Udompornmongkol P; Chiang BH
J Biomater Appl; 2015 Nov; 30(5):537-46. PubMed ID: 26170212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
